Age and amyloid effects on human central nervous system amyloid-beta kinetics.

Ann Neurol 2015 Sep 20;78(3):439-53. Epub 2015 Jul 20.

Department of Neurology, Washington University in St. Louis, St. Louis, MO.

Objective: Age is the single greatest risk factor for Alzheimer's disease (AD), with the incidence doubling every 5 years after age 65. However, our understanding of the mechanistic relationship between increasing age and the risk for AD is currently limited. We therefore sought to determine the relationship between age, amyloidosis, and amyloid-beta (Aβ) kinetics in the central nervous system (CNS) of humans.

Methods: Aβ kinetics were analyzed in 112 participants and compared to the ages of participants and the amount of amyloid deposition.

Results: We found a highly significant correlation between increasing age and slowed Aβ turnover rates (2.5-fold longer half-life over five decades of age). In addition, we found independent effects on Aβ42 kinetics specifically in participants with amyloid deposition. Amyloidosis was associated with a higher (>50%) irreversible loss of soluble Aβ42 and a 10-fold higher Aβ42 reversible exchange rate.

Interpretation: These findings reveal a mechanistic link between human aging and the risk of amyloidosis, which may be owing to a dramatic slowing of Aβ turnover, increasing the likelihood of protein misfolding that leads to deposition. Alterations in Aβ kinetics associated with aging and amyloidosis suggest opportunities for diagnostic and therapeutic strategies. More generally, this study provides an example of how changes in protein turnover kinetics can be used to detect physiological and pathophysiological changes and may be applicable to other proteinopathies.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546566PMC
September 2015
74 Reads

Publication Analysis

Top Keywords

aβ kinetics
12
increasing age
8
aβ turnover
8
nervous system
8
central nervous
8
age
7
kinetics
6
5
25-fold longer
4
longer half-life
4
half-life decades
4
amyloidosis opportunities
4
age addition
4
aβ42 kinetics
4
kinetics participants
4
participants amyloid
4
effects aβ42
4
independent effects
4
rates 25-fold
4
aging amyloidosis
4

Similar Publications